Interleukin-6 May Contribute to Mortality in Parkinson’s Disease Patients: A 4-Year Prospective Study
Objectives. The association between abnormal serum immunomarkers and mortality in 53 consecutive Parkinson’s disease patients was studied. Materials and Methods. The plasma level of specific inflammatory cytokines was investigated: mannan-binding lectin (MBL), interleukin- (IL-) 6, and tumor necrosi...
Saved in:
| Main Authors: | Michal Dufek, Irena Rektorova, Vojtech Thon, Jindrich Lokaj, Ivan Rektor |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Parkinson's Disease |
| Online Access: | http://dx.doi.org/10.1155/2015/898192 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dorsolateral Prefrontal Cortex: A Possible Target for Modulating Dyskinesias in Parkinson's Disease by Repetitive Transcranial Magnetic Stimulation
by: I. Rektorova, et al.
Published: (2008-01-01) -
Nonmotor Symptoms of Parkinson's Disease
by: Irena Rektorova, et al.
Published: (2011-01-01) -
Interleukin-6 Does Not Contribute to Neurogenic Heterotopic Ossification Pathogenesis
by: Dorothée Girard, et al.
Published: (2024-11-01) -
Interleukin-6 Contributes to Age-Related Alteration of Cytokine Production by Macrophages
by: Christian R. Gomez, et al.
Published: (2010-01-01) -
Revealing connectivity patterns of deep brain stimulation efficacy in Parkinson’s disease
by: Eva Výtvarová, et al.
Published: (2024-12-01)